Mengmeng Shi

431 total citations
20 papers, 289 citations indexed

About

Mengmeng Shi is a scholar working on Molecular Biology, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mengmeng Shi has authored 20 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Neurology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mengmeng Shi's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological diseases and metabolism (4 papers) and RNA regulation and disease (3 papers). Mengmeng Shi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological diseases and metabolism (4 papers) and RNA regulation and disease (3 papers). Mengmeng Shi collaborates with scholars based in China, Hong Kong and United States. Mengmeng Shi's co-authors include Changhe Shi, Yuming Xu, Kwong Wai Choy, Jing Yang, Tak Yeung Leung, Matthew Hoi Kin Chau, Yvonne K. Kwok, Zirui Dong, Chengyuan Mao and Shuyu Zhang and has published in prestigious journals such as Cancer Research, Scientific Reports and Frontiers in Microbiology.

In The Last Decade

Mengmeng Shi

18 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengmeng Shi China 10 99 90 81 74 44 20 289
Marisol Mirabelli-Badenier Italy 10 104 1.1× 44 0.5× 100 1.2× 51 0.7× 14 0.3× 13 238
Mathilde Nizon France 13 239 2.4× 15 0.2× 153 1.9× 41 0.6× 26 0.6× 26 387
Ichraf Kraoua Tunisia 9 112 1.1× 111 1.2× 54 0.7× 15 0.2× 9 0.2× 64 270
Ligia Mateiu Belgium 12 285 2.9× 19 0.2× 157 1.9× 98 1.3× 17 0.4× 29 480
Susan M. Cochrane United Kingdom 10 133 1.3× 71 0.8× 24 0.3× 32 0.4× 22 0.5× 15 355
Emily Bonkowski United States 4 118 1.2× 37 0.4× 72 0.9× 8 0.1× 18 0.4× 11 277
Radek Vodička Czechia 8 64 0.6× 57 0.6× 86 1.1× 25 0.3× 5 0.1× 35 252
Izabella Baranowska Körberg Sweden 8 112 1.1× 17 0.2× 85 1.0× 30 0.4× 34 0.8× 12 272
Eda Ütine Türkiye 9 96 1.0× 21 0.2× 99 1.2× 20 0.3× 16 0.4× 24 218
Ling Ouyang United States 4 300 3.0× 22 0.2× 216 2.7× 23 0.3× 9 0.2× 8 465

Countries citing papers authored by Mengmeng Shi

Since Specialization
Citations

This map shows the geographic impact of Mengmeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Shi more than expected).

Fields of papers citing papers by Mengmeng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengmeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Shi. The network helps show where Mengmeng Shi may publish in the future.

Co-authorship network of co-authors of Mengmeng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Mengmeng Shi. A scholar is included among the top collaborators of Mengmeng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengmeng Shi. Mengmeng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Mengmeng, et al.. (2025). Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation. Urolithiasis. 53(1). 27–27. 1 indexed citations
2.
Liu, Yi, et al.. (2024). Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus. International Urology and Nephrology. 56(12). 3845–3855.
3.
Chau, Matthew Hoi Kin, Ying Li, Peng Dai, et al.. (2022). Investigation of the genetic etiology in male infertility with apparently balanced chromosomal structural rearrangements by genome sequencing. Asian Journal of Andrology. 24(3). 248–254. 12 indexed citations
4.
Lau, Tze Kin, Anita Sik Yau Kan, Brian Hon‐Yin Chung, et al.. (2021). A Fetus with Congenital Microcephaly, Microphthalmia and Cataract Was Detected with Biallelic Variants in the OCLN Gene: A Case Report. Diagnostics. 11(9). 1576–1576.
5.
Shi, Mengmeng, Xinyi Leng, Ying Li, et al.. (2021). Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease. Stroke and Vascular Neurology. 7(3). 182–189. 6 indexed citations
6.
Liu, Jinxin, Mengmeng Shi, Qing Zhao, et al.. (2021). Precise Species Detection in Traditional Herbal Patent Medicine, Qingguo Wan, Using Shotgun Metabarcoding. Frontiers in Pharmacology. 12. 607210–607210. 10 indexed citations
7.
Dong, Zirui, Matthew Hoi Kin Chau, Yanyan Zhang, et al.. (2021). Low-pass genome sequencing–based detection of absence of heterozygosity: validation in clinical cytogenetics. Genetics in Medicine. 23(7). 1225–1233. 23 indexed citations
8.
Shi, Mengmeng, Steven Y. C. Tong, Yu Zheng, et al.. (2021). Clinical Implementation of Expanded Carrier Screening in Pregnant Women at Early Gestational Weeks: A Chinese Cohort Study. Genes. 12(4). 496–496. 13 indexed citations
9.
Chau, Matthew Hoi Kin, Xiaofan Zhu, Yuen Ha Ting, et al.. (2020). The utility of genome‐wide cell‐free DNA screening in the prenatal diagnosis of Pallister‐Killian syndrome. Prenatal Diagnosis. 40(8). 1005–1012. 4 indexed citations
10.
Choy, Kwong Wai, Huilin Wang, Mengmeng Shi, et al.. (2019). Prenatal Diagnosis of Fetuses With Increased Nuchal Translucency by Genome Sequencing Analysis. Frontiers in Genetics. 10. 761–761. 51 indexed citations
11.
Yang, Zhihua, Yusheng Li, Mengmeng Shi, et al.. (2019). SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson’s disease in Chinese population. Journal of Neurology. 266(7). 1796–1800. 8 indexed citations
12.
Shi, Mengmeng, Antoine Monsel, Jean‐Jacques Rouby, et al.. (2019). Inoculation Pneumonia Caused by Coagulase Negative Staphylococcus. Frontiers in Microbiology. 10. 2198–2198. 9 indexed citations
13.
Zhao, Jingya, Mingxiang Feng, Dong Liu, et al.. (2019). Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non–Small Cell Lung Cancer. Cancer Research. 79(11). 2853–2864. 21 indexed citations
14.
Shi, Changhe, Fang Li, Mengmeng Shi, et al.. (2017). Genetic analysis of the TMEM230 gene in Chinese Han patients with Parkinson’s disease. Scientific Reports. 7(1). 1190–1190. 7 indexed citations
15.
Shi, Mengmeng, Changhe Shi, & Yuming Xu. (2017). Rab GTPases: The Key Players in the Molecular Pathway of Parkinson’s Disease. Frontiers in Cellular Neuroscience. 11. 81–81. 49 indexed citations
16.
Wang, Yanlin, Huifang Sun, Zhihua Yang, et al.. (2017). Generation of induced pluripotent stem cell line (ZZUi005-A) from a 21-year-old patient with a novel RAB39B gene mutation in X-linked juvenile parkinsonism. Stem Cell Research. 25. 132–135. 6 indexed citations
17.
Shi, Changhe, Shuyu Zhang, Zhi-hua Yang, et al.. (2016). A novel RAB39B gene mutation in X‐linked juvenile parkinsonism with basal ganglia calcification. Movement Disorders. 31(12). 1905–1909. 37 indexed citations
18.
Mao, Chengyuan, Jing Yang, Hui Wang, et al.. (2016). SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease. Parkinsonism & Related Disorders. 34. 59–61. 25 indexed citations
19.
Shi, Changhe, Jing Yang, Shuyu Zhang, et al.. (2016). DNAJC6 mutations are not common causes of early onset Parkinson’s disease in Chinese Han population. Neuroscience Letters. 634. 60–62. 5 indexed citations
20.
Assadi, Farahnak, et al.. (1999). Effects of pre- and postnatal cysteamine exposure on renal function in the rat. Pediatric Nephrology. 13(9). 812–815. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marisol Mirabelli-Badenier Breakdown of academic impact, for papers by Mathilde Nizon Breakdown of academic impact, for papers by Ichraf Kraoua Breakdown of academic impact, for papers by Ligia Mateiu Breakdown of academic impact, for papers by Susan M. Cochrane Breakdown of academic impact, for papers by Emily Bonkowski Breakdown of academic impact, for papers by Radek Vodička Breakdown of academic impact, for papers by Izabella Baranowska Körberg Breakdown of academic impact, for papers by Eda Ütine Breakdown of academic impact, for papers by Ling Ouyang
Rankless by CCL
2026